PATENTS OFFICE JOURNAL - Irish Patents Office

34 (No. 2037) Patents Office Journal (11/01/2006)
Supplementary Protection Certificates Granted
The name and address of the grantee follows the number allocated to the application for grant of a certificate;
this number applies also to the granted certificate. The date in brackets following the name and address is the
date of grant of the certificate. The number of the basic Patent and the title of the invention are followed by
the name of the product for which the certificate is granted. Market authorisation references in respect of the
product concerned are also shown, followed by the date of expiry of the certificate.
2001014 WYETH HOLDINGS CORPORATION, Five Giralda Farms, Madison, New
Jersey, 07940, United States of America
16/12/2005
Patent No: 60897; Immunogenic conjugates
Product: A vaccine comprising pneumoccal saccharides of serotypes 4, 6B, 9V,
14, 18C, 19F and 23F, each conjugated to the CRM197 carrier protein.
Market Authorisation: Ireland EU/1/00/167/001,002,003,004, 02/02/2001
Switzerland 643, 16/03/2000
Certificate Expires on: 10/05/2012
2004006 NOVARTIS AG, Schwarzwaldallee 215, 4058 Basel, Switzerland
15/12/2005
Patent No: 57541; 20-Spiroxanes and analogues having an open ring e, processes
for their manufacture, and pharmaceutical preparations thereof
Product: Eplerenone or its pharmaceutically acceptable salts thereof
Market Authorisation: Ireland 822/20/1, 822/20/2, 20/08/2004
Ireland RVG 29964, 16/03/2004
The Netherlands RVG29963, 16/03/2004
Certificate Expires on: 11/04/2009
Supplementary Protection Certificates Withdrawn
The name and address of the requestor follow the number allocated to the request. The date in brackets,
following the name and address, is the date of receipt of the request. The patent number is that under which
the product in respect of which a certificate is sought is, allegedly, protected. Market authorisation references
in respect of the product concerned are also shown.
2001/015 WYETH HOLDINGS CORPORATION
Five Giralda Farms, Madison, New Jersey 07940-0874,
United States of America
(27 July 2001)
Patent No. 60897
Product:
Immunogenic Conjugates
Pneumococcal oligosaccharide serotype 18C conjugate
Market Authorisation: EU/1/00/167/001-004 (2 February 2001)